Pelthos Therapeutics Inc. held annual shareholder meeting
I'm PortAI, I can summarize articles.
Pelthos Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on December 17, 2025. All seven director nominees were elected, and stockholders approved the waiver on the share issuance limit for senior secured convertible notes. The appointment of CBIZ CPAs P.C. as the independent accounting firm for 2025 was ratified.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments